Literature DB >> 2586218

Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats.

L J Porrino1, M C Ritz, N L Goodman, L G Sharpe, M J Kuhar, S R Goldberg.   

Abstract

The effects of the administration of serotonergic drugs on infusion rates of rats self-administering cocaine and amphetamine on an FR-10 schedule of reinforcement in daily 4 hour sessions were compared. Pretreatment with fluoxetine (2.5, 5, and 10 mg/kg), an inhibitor of serotonin reuptake, significantly decreased rates of responding maintained by amphetamine, but had no effect on responding maintained by cocaine at any of the doses tested. Pretreatment with cinanserin (3, 10, and 17.5 mg/kg), a serotonergic receptor antagonist, decreased rates of amphetamine self-administration at the highest dose tested, and also had no effect on cocaine self-administration. These data suggest a differential sensitivity of cocaine and amphetamine self-administration to pharmacological manipulation of central serotonin systems. They are consistent with biochemical data which demonstrates a negative correlation between the reinforcing potency of amphetamine-like drugs, but not cocaine-like drugs and their potency at serotonin binding sites.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2586218     DOI: 10.1016/0024-3205(89)90418-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  17 in total

1.  Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine.

Authors:  R Ranaldi; R A Wise
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

2.  Role of serotonin in cocaine effects in mice with reduced dopamine transporter function.

Authors:  Yolanda Mateo; Evgeny A Budygin; Carrie E John; Sara R Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

3.  Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.

Authors:  Sean P David; Elaine C Johnstone; Michael F G Murphy; Paul Aveyard; Boliang Guo; Caryn Lerman; Marcus R Munafò
Journal:  Drug Alcohol Depend       Date:  2008-06-17       Impact factor: 4.492

4.  Mechanisms of acute cocaine toxicity.

Authors:  Kennon Heard; Robert Palmer; Nancy R Zahniser
Journal:  Open Pharmacol J       Date:  2008

5.  Chromosomal mapping of the psychomotor stimulant effects of cocaine in BXD recombinant inbred mice.

Authors:  L L Miner; R J Marley
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

Review 6.  Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.

Authors:  P De Deurwaerdère; M Lagière; M Bosc; S Navailles
Journal:  Exp Brain Res       Date:  2013-04-25       Impact factor: 1.972

7.  Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys.

Authors:  R D Spealman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Effects of serotonergic manipulations on cocaine self-administration in rats.

Authors:  R Peltier; S Schenk
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Adaptations in pre- and postsynaptic 5-HT1A receptor function and cocaine supersensitivity in serotonin transporter knockout rats.

Authors:  Judith R Homberg; Sietse F De Boer; Halfdan S Raasø; Jocelien D A Olivier; Mark Verheul; Eric Ronken; Alexander R Cools; Bart A Ellenbroek; Anton N M Schoffelmeer; Louk J M J Vanderschuren; Taco J De Vries; Edwin Cuppen
Journal:  Psychopharmacology (Berl)       Date:  2008-06-27       Impact factor: 4.530

10.  Time-dependent recovery from the effects of 6-hydroxydopamine lesions of the rat nucleus accumbens on cocaine self-administration and the levels of dopamine in microdialysates.

Authors:  Glen M Sizemore; Conchita Co; Timothy R Koves; Thomas J Martin; James E Smith
Journal:  Psychopharmacology (Berl)       Date:  2003-09-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.